FI113548B - Synteettinen indusoituva eukarioottinen promoottori geenin kopioitumisen säätelemiseksi - Google Patents

Synteettinen indusoituva eukarioottinen promoottori geenin kopioitumisen säätelemiseksi Download PDF

Info

Publication number
FI113548B
FI113548B FI944451A FI944451A FI113548B FI 113548 B FI113548 B FI 113548B FI 944451 A FI944451 A FI 944451A FI 944451 A FI944451 A FI 944451A FI 113548 B FI113548 B FI 113548B
Authority
FI
Finland
Prior art keywords
promoter
elements
native
inducible
gre
Prior art date
Application number
FI944451A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI944451A (fi
FI944451A0 (fi
Inventor
Jorge Filmus
Michel Klein
Original Assignee
Connaught Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Lab filed Critical Connaught Lab
Publication of FI944451A publication Critical patent/FI944451A/fi
Publication of FI944451A0 publication Critical patent/FI944451A0/fi
Application granted granted Critical
Publication of FI113548B publication Critical patent/FI113548B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Soil Working Implements (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Electrotherapy Devices (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Multicomponent Fibers (AREA)
FI944451A 1992-03-30 1994-09-26 Synteettinen indusoituva eukarioottinen promoottori geenin kopioitumisen säätelemiseksi FI113548B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9206874 1992-03-30
GB929206874A GB9206874D0 (en) 1992-03-30 1992-03-30 Generation of improved inducible mammalian expression vectors
CA9300130 1993-03-30
PCT/CA1993/000130 WO1993020218A1 (fr) 1992-03-30 1993-03-30 Promoteurs eucaryotiques de synthese a deux elements inductibles

Publications (3)

Publication Number Publication Date
FI944451A FI944451A (fi) 1994-09-26
FI944451A0 FI944451A0 (fi) 1994-09-26
FI113548B true FI113548B (fi) 2004-05-14

Family

ID=10713085

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944451A FI113548B (fi) 1992-03-30 1994-09-26 Synteettinen indusoituva eukarioottinen promoottori geenin kopioitumisen säätelemiseksi

Country Status (17)

Country Link
US (1) US5559027A (fr)
EP (1) EP0633941B1 (fr)
JP (1) JP2701983B2 (fr)
KR (1) KR100208311B1 (fr)
AT (1) ATE217649T1 (fr)
AU (1) AU667532B2 (fr)
BR (1) BR9306167A (fr)
CA (1) CA2128602C (fr)
DE (1) DE69331931T2 (fr)
DK (1) DK0633941T3 (fr)
ES (1) ES2176202T3 (fr)
FI (1) FI113548B (fr)
GB (1) GB9206874D0 (fr)
NO (1) NO316451B1 (fr)
PT (1) PT633941E (fr)
RU (1) RU2128225C1 (fr)
WO (1) WO1993020218A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071695A (en) * 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
US5512483A (en) * 1993-05-21 1996-04-30 Mcgill University Expression vectors responsive to steroid hormones
JPH07163368A (ja) * 1993-12-15 1995-06-27 Hayashibara Biochem Lab Inc 組換えｄｎａとその組換えｄｎａを含む形質転換体
JPH10505223A (ja) * 1994-06-07 1998-05-26 クリエイティブ バイオモレキュールズ， インコーポレイテッド 形態形成タンパク質発現を調節するための方法および組成物
JP2001509395A (ja) 1997-07-14 2001-07-24 バレンティス・インコーポレーテッド 細胞又は組織特異的な人工転写調節領域の同定方法
JP2001520170A (ja) 1997-10-16 2001-10-30 ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム Ｎｆ−ａｔ３機能に関連した心肥大動物モデルと治療法
FR2772786A1 (fr) * 1997-12-18 1999-06-25 Inst Nat Sante Rech Med Sequences nucleotidiques chevauchantes, et leur utilisation dans le cadre de la detection de xenohormones ainsi que dans des compositions pharmaceutiques
CA2362970A1 (fr) * 1999-02-19 2000-08-24 Octagene Gmbh Couples hormone-recepteur hormonal, constructions d'acides nucleiques, et utilisation de ceux-ci en therapie genique
US8008459B2 (en) * 2001-01-25 2011-08-30 Evolva Sa Concatemers of differentially expressed multiple genes
US7341847B2 (en) * 2003-04-02 2008-03-11 Agency For Science, Technology And Research Promoter construct for gene expression in neuronal cells
WO2005046450A2 (fr) 2003-11-12 2005-05-26 Children's Hospital Medical Center Procede de diagnostic et de traitement de troubles pulmonaires
KR100647490B1 (ko) * 2004-10-04 2006-11-23 사회복지법인 삼성생명공익재단 저산소 조건 및 다른 스트레스에 특이적으로 반응할 수있는 키메라 인핸서 요소를 포함하는 벡터, 상기 벡터를포함하는 약제학적 조성물 및 상기 조성물을 이용하는 방법
US8921109B2 (en) 2005-09-19 2014-12-30 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
KR101369237B1 (ko) * 2006-09-04 2014-03-04 바이오-에너지가부시키가이샤 폴리에스테르 폴리올
RU2370280C2 (ru) * 2007-10-08 2009-10-20 Институт физико-химической биологии им. А.Н.Белозерского СПОСОБ СУПЕРПРОДУКЦИИ В РАСТЕНИИ АНТИТЕЛ ПРОТИВ ОНКОГЕНА HER2/neu
US8551733B2 (en) 2009-02-09 2013-10-08 Morphosys Ag Production of oligoclonal mixtures of immunoglobulins in single cells
EP2571991A1 (fr) 2010-05-20 2013-03-27 Evolva SA Procédé de fabrication de composés isoprénoïdes dans une levure
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
BR112020010928A2 (pt) 2017-11-30 2020-11-24 Friedrich Miescher Institute For Biomedical Research synpiii, um promotor para a expressão de gene específica em epitélio de pigmento retinal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE72583T1 (de) * 1981-11-23 1992-02-15 University Patents Inc Steuerung der dna-sequenzen-transkription.
JP2746480B2 (ja) * 1990-01-18 1998-05-06 アメリカ合衆国 遺伝子発現に影響を与える多重標的応答因子をもつベクター
CA2075182C (fr) * 1990-02-09 2003-03-25 David J. Mangelsdorf Compositions et methodes receptrices retinoides

Also Published As

Publication number Publication date
FI944451A (fi) 1994-09-26
US5559027A (en) 1996-09-24
DK0633941T3 (da) 2002-06-17
FI944451A0 (fi) 1994-09-26
KR100208311B1 (ko) 1999-07-15
NO316451B1 (no) 2004-01-26
WO1993020218A1 (fr) 1993-10-14
PT633941E (pt) 2002-10-31
RU2128225C1 (ru) 1999-03-27
JPH07501456A (ja) 1995-02-16
ES2176202T3 (es) 2002-12-01
AU667532B2 (en) 1996-03-28
BR9306167A (pt) 1998-01-13
RU94042389A (ru) 1997-03-10
JP2701983B2 (ja) 1998-01-21
KR950700420A (ko) 1995-01-16
NO943610D0 (no) 1994-09-29
ATE217649T1 (de) 2002-06-15
GB9206874D0 (en) 1992-05-13
AU3883393A (en) 1993-11-08
CA2128602A1 (fr) 1993-10-14
CA2128602C (fr) 2008-01-22
DE69331931T2 (de) 2002-09-12
EP0633941B1 (fr) 2002-05-15
EP0633941A1 (fr) 1995-01-18
DE69331931D1 (de) 2002-06-20
NO943610L (no) 1994-11-30

Similar Documents

Publication Publication Date Title
FI113548B (fi) Synteettinen indusoituva eukarioottinen promoottori geenin kopioitumisen säätelemiseksi
AU660405B2 (en) Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators
JP4307079B2 (ja) マトリックス付着領域およびその使用方法
Yang et al. Human GATA-3 trans-activation, DNA-binding, and nuclear localization activities are organized into distinct structural domains
Späth et al. Hepatocyte nuclear factor 4 expression overcomes repression of the hepatic phenotype in dedifferentiated hepatoma cells
Martinez-Salas et al. The need for enhancers in gene expression first appears during mouse development with formation of the zygotic nucleus.
US10590434B2 (en) Highly inducible dual-promoter lentiviral TET-ON system
US8263393B2 (en) Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
AU2005261699B2 (en) Novel sequence for improving expression of nucleic acid
ES2439874T3 (es) Sistema de expresión en eucariotas inducible
KR20000029120A (ko) 에피솜-복제 벡터, 이의 제법 및 이의 용도
WO2005059149A2 (fr) Fabrication amelioree de proteines
JPH0235091A (ja) 哺乳動物細胞における発現の制御
JP2023528291A (ja) テトラサイクリンとＣｕｍａｔｅに基づく共制御配列
US5877018A (en) Synthetic eukaryotic promoters containing two inducible elements
KR102590276B1 (ko) 조직 특이적 발현을 위한 융합 프로모터 및 이의 용도
Günther et al. Simian virus 40 strains with novel properties generated by replacing the viral enhancer with synthetic oligonucleotides
US7504492B2 (en) RNA polymerase III promoter, process for producing the same and method of using the same
JPH1094393A (ja) 生理活性物質産生用ターゲッティングベクター
Alouani et al. Expression of heat shock-regulated human growth hormone genes containing or lacking introns by NIH-3T3 and wish cell lines
AU2003291852A1 (en) Genetic therapy and genetic modification using neocentromeric minichromosomes
Kennington et al. Evidence that Tristetraprolin Binds to
EP1763586A2 (fr) Nouvelle sequence pour ameliorer l'expression d'acide nucleique

Legal Events

Date Code Title Description
MA Patent expired